When EU legislation on pharmacovigilance came into force in July 2012, it established the clear legal requirement that marketing authorisation holders must perform audits of …

Automating regulatory processes delivers undeniable benefits, ranging from accelerating time to market to reducing error. But life sciences companies are widely grappling with the basic …

The COVID-19 pandemic has stretched healthcare suppliers, organisations, governments, and healthcare professionals to their very limits, locking down the world like never before. Healthcare industries, …

The development of vaccines to prevent COVID-19 has become a fascinating story, especially for those with an interest in life sciences. In the development of …

The COVID-19 pandemic era is shaking up the pharma supply chain. Heavily regulated processes that used to take years are speeding up as existing drugs …

In June, the first part of this article was published, describing differences in the legal background of some of the European Union countries, which need …

Under growing pressure resulting from staff shortages, overburdened funding, an ageing population and most recently a global pandemic, healthcare systems across the world are supporting …

In the quest to find new and more effective treatments against severe diseases, researchers are increasingly moving towards active pharmaceutical ingredients (APIs) with increased potency …

Recent data suggest that 339M people globally have asthma, resulting in 425,000 deaths annually, many of which would be preventable with access to medication and …

Recent decades have seen vast technological developments all over the world, particularly in respiratory drug development. Respiratory drug delivery has equally been defined by the …